Fact CheckerSign in

NCT07359625Recruiting

Effects of Ketone Bodies on Insulin Sensitivity

KETO-SENSE - Effects of Ketone Bodies on Insulin Sensitivity

Source: ClinicalTrials.gov · Last updated 22 Jan 2026

Brief summary (registry, in English)

KETO-SENSE is a clinical research study investigating how ketone bodies affect energy metabolism and insulin sensitivity in humans. Ketone bodies are naturally produced by the liver during fasting or prolonged exercise and can serve as an alternative fuel for the brain, heart, and muscles. In this study, ten overweight but otherwise healthy adults aged 55-70 years will participate in four study days at Aarhus University Hospital. Participants will receive one of four interventions in a randomized crossover design: 1) growth hormone (GH) and a ketone supplement, 2) GH and placebo, 3) a saline infusion with the ketone supplement, or 4) placebo (saline infusion and placebo supplement). The study uses advanced PET/CT imaging, indirect calorimetry, and tissue biopsies to measure how ketones influence fat breakdown, glucose uptake, and energy expenditure. By understanding these mechanisms, the study aims to clarify whether oral ketone supplementation can improve insulin sensitivity and energy metabolism - findings that could be relevant for common conditions such as overweight, insulin resistance, and type 2 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
10 (estimated)
First submitted
14 Nov 2025
Start date
2 Dec 2025
Primary completion date
Apr 2027
Lead sponsor
University of Aarhus
Diseases
Obesity
NCT number
NCT07359625

What you commit to

  • Study type: Interventional
  • Planned participants: 10
  • From 2 Dec 2025 to the primary completion date, Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • \- Any evidence of acute or chronic illnesses, apart from well-controlled hypertension, that is judged by the investigators to impact the study

Who the study is looking for

  • Age range: 55-70 yr
  • BMI: 25 - 35 kg/m2

Age in the registry: 55 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Aarhus University Hospital
Coordinator of this site? Confirm its status
Aarhus NDenmarkRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.